, Genetic testing for cancer susceptibility, Journal ofClinical Oncology, vol.14, pp.1730-1736, 1996.

, Statement of the american society of human genetics on genetic testing for breast cancer prédisposition, American Society of Human Genetics, p.55, 1994.

, Position statement on gène patents and accessibility of gène testing, American Collège of Médical Genetics, 1999.

D. Cohen, Les gènes de l'espoir, 1993.

F. Collins, Genetic screening for breast cancer, The New England Journal of Médecine, vol.334, pp.1200-1201, 1996.

J. Dausset, Clin d'oeil à la vie. La grande aventure HLA, 1998.

R. Eisenberg, The move towards the privatization of biomédical research, The future of biomédical research, 1997.

J. P. Gaudillière, Circulating mice and viruses. The Jackson Mémorial Laboratory, the National Cancer Institute, and the Genetics of Breast Cancer, The pratices of human genetics, 1999.

M. Gibbons, C. Limoges, H. Nowotny, S. Schwartzman, P. Scott et al., The new production ofknowledge, 1994.

N. Holtzman and S. Watson, Promoting safe and effective genetic testing in the United States, Final report of the task force on genetic testing, 1998.

N. A. Holtzman, Are genetic tests adequately regulated?, Science, pp.286-409, 1999.
DOI : 10.1126/science.286.5439.409

I. and E. Collective, Risques héréditaires des cancers du sein et de l'ovaire. Quelle prise en charge ?, 1998.

C. Labrusse-riou, . Servitudes, :. In, . L'homme, C. Paris et al., National Advisory Council for Human Génome Research, 1994, Statement on use of DNA testing for presymptomatic identification of cancer risk, JAMA, pp.271-785

J. Rifkin, Le siècle Biotech. Le commerce des gènes, 1998.

D. Stoppa-lyonnet, C. Blandy, and F. Eisinger, Cancer du sein : évaluer le risque. Les tests génétiques donnent naissance à une médecine de l'incertain, La Recherche, vol.294, pp.72-76, 1997.

E. P. Thompson, Customs in common, 1991.